Farrow Financial »

Crispr Therapeutics shares owned by Farrow Financial

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Farrow Financial from 13F filings

Historical chart of Farrow Financial investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Farrow Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Farrow Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.2M 17k 68.16
2023-12-31 $1.2M 19k 62.60

More positions owned by Farrow Financial

Ishares Tr Core S&p Ttl Stk (ITOT)
Apple (AAPL)
Ishares Tr Msci Usa Esg Slc (SUSA)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Ishares Tr Msci Intl Vlu Ft (IVLU)
Ishares Tr Blackrock Ultra (ICSH)
Ishares Tr Core Msci Eafe (IEFA)
NVIDIA Corporation (NVDA)
Amplify Etf Tr Cwp Enhanced Div (DIVO)
Badger Meter (BMI)
Microsoft Corporation (MSFT)
Spdr Ser Tr Prtflo S&p500 Hi (SPYD)
Intel Corporation (INTC)
MasTec (MTZ)
Vulcan Materials Company (VMC)

View all positions for Farrow Financial

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
BlackRock
Citadel Advisors
Vanguard Group
NEA Management Company
Susquehanna International
Caption Management
Dimensional Fund Advisors
Bellevue Group
T. Rowe Price Associates
Bank of America Corporation
Voloridge Investment Management
Ikarian Capital

View all funds holding Crispr Therapeutics